Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy

Millions of individuals who have recovered from SARS-CoV-2 infection may be eligible to participate in convalescent plasma donor programs, yet the optimal window for donating high neutralizing titer convalescent plasma for COVID-19 immunotherapy remains unknown. Here we studied the response trajecto...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Commun Biol
Egile Nagusiak: Gontu, Abhinay, Srinivasan, Sreenidhi, Salazar, Eric, Nair, Meera Surendran, Nissly, Ruth H., Greenawalt, Denver, Bird, Ian M., Herzog, Catherine M., Ferrari, Matthew J., Poojary, Indira, Katani, Robab, Lindner, Scott E., Minns, Allen M., Rossi, Randall, Christensen, Paul A., Castillo, Brian, Chen, Jian, Eagar, Todd N., Yi, Xin, Zhao, Picheng, Leveque, Christopher, Olsen, Randall J., Bernard, David W., Gollihar, Jimmy, Kuchipudi, Suresh V., Musser, James M., Kapur, Vivek
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7904946/
https://ncbi.nlm.nih.gov/pubmed/33627795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-021-01813-y
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak